Delivery Order SPE2DR25D9331-SPE2DR26FQQL6

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for 3,750 units of Oncaspar 5 mL vials with a ceiling value of $40,717.98. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's indefinite delivery contract vehicle for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations globally. DMS Pharmaceutical Group is a...

The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 3,750 units of Oncaspar 5 ml vials valued at $40,717.98. The award, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, carries a firm fixed-price structure with no small business set-aside designation, indicating the contractor competed in open federal procurement. This delivery...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,717.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on January 22, 2026. The delivery order covers 3,750 units of Oncaspar 5 milliliter vials, an oncology pharmaceutical product, with a firm fixed-price structure and an ultimate completion date of February 12, 2026. This award was issued without a set-aside designation, reflecting the contractor's...

The Defense Logistics Agency awarded a delivery order valued at $27,351.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 3,750 units of Oncaspar (5 mL vials). This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, was awarded without a set-aside designation. The contract falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $27,351.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order, issued on October 27, 2025, procures 3,750 units of Oncaspar 5 mL vials, an oncology pharmaceutical product, with completion scheduled for November 18, 2025. This award was made without set-aside designation, demonstrating the contractor's competitive...

The Defense Logistics Agency issued a $3,863.68 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting Department of Defense medical supply needs. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is firm fixed price with place of performance in Park Ridge, Illinois. Ultimate completion is March 4, 2026. The ceiling value equals the obligated...

The Defense Logistics Agency issued a $65,066.40 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense medical facilities worldwide; DMS Pharmaceutical Group's...

The Defense Logistics Agency (DLA) awarded a $49,531.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,561,926,430 units of the oncology medication Oncaspar in 5 mL vials. This contract is not associated with a set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 single-award Indefinite Delivery Contract (IDC) with the...

The Defense Logistics Agency issued a $1,506.40 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance...

The Defense Logistics Agency issued a $1,186.64 delivery order to DMS Pharmaceutical Group Inc. on March 7, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide, with a $499.9...